Abstract

Theeffect of antioxidant (Vitamin E) on the efficacy of Artesunate was investigated using Plasmodium berghei infected mice. Fifty (50) adult albino mice weighing between 15-25g were used for this study. There were five groups of ten animals each per group. Group I was the normal control group without the parasite and untreated, group II was infected with malaria parasite and 0.9% normal saline was administered, group III was infected with the parasite and treated with artesunate, group IV was infected with the parasaite and vitamin E was administered and group V was infected with the parasite and combination of artesunate and vitamin E were administered. Parasitaemia level and haematocrit (PCV) were monitored upon the administration of antimalaria drug - artesunate, vitamin E, normal saline and combination therapy of both vitamin E and artesunate. The life span of the infected mice was found to be between the 7 and the 10 day post inoculation, while the LD of the parasite was 156626.2 parasite/μl of blood. Artesunate was observed to rapidly clear the parasite with parasitaemia level of 21632.4 ± 513.3 parasite/μl on the 6 day, 11209.9 ± 363.7 parasite/μl on the 7 day, 1359.7 ± 14.3 parasite/μl on the 8 day, 7.8 ± 2.4 parasite/μl on the 9 day and zero parasitaemia on the 10 day. The effect of artesunate was significantly reduced when co-administered with vitamin E (p (Afr. J. Biomed. Res. 10: 51 – 57, January 2007) Keywords: Plasmodium berghei, Parasitaemia, Artesunate, Vitamin E, mice.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call